NEUBASE THERAPEUTICS INCNEUBASE THERAPEUTICS INCNEUBASE THERAPEUTICS INC

NEUBASE THERAPEUTICS INC

No trades
See on Supercharts
Next report date
Report period
Q4 2023
EPS estimate
−33.15MXN
Revenue estimate
Market capitalization
‪28.53 M‬MXN
−170.14MXN
‪3.04 M‬
Beta (1Y)
1.18

About NeuBase Therapeutics, Inc.

CEO
Todd P. Branning
Headquarters
Pittsburgh
Founded
2009
FIGI
BBG00Z1WHW74
NeuBase Therapeutics, Inc. is a biotechnology company, which engages in the development of drugs for patients with genetic neurological disorders. The firm’s therapies are built on a proprietary platform called PATrOL that encompasses a novel peptide-nucleic acid antisense oligonucleotide technology combined with novel delivery shuttles that overcome many of the hurdles to selective mutation engagement, repeat dosing, and systemic delivery of genetic medicines. The company was founded by Dietrich A. Stephan on August 4, 2009 and is headquartered in Pittsburgh, PA.
Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:
‪0.00‬

See all ideas 

Summarizing what the indicators are suggesting.
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.

Frequently Asked Questions

The current price of NBSE is 51.37 MXN — it has increased by 144.64% in the past 24 hours.
Depending on the exchange, the stock ticker may vary. For instance, on BMV exchange NEUBASE THERAPEUTICS INC stocks are traded under the ticker NBSE.
NEUBASE THERAPEUTICS INC is going to release the next earnings report on May 14, 2024. Keep track of upcoming events with our Earnings Calendar.
NBSE stock is 59.12% volatile and has beta coefficient of 1.18. Check out the list of the most volatile stocks — is NEUBASE THERAPEUTICS INC there?
NBSE earnings for the last quarter are −31.20 MXN per share, whereas the estimation was −36.00 MXN resulting in a 13.33% surprise. The estimated earnings for the next quarter are −16.91 MXN per share. See more details about NEUBASE THERAPEUTICS INC earnings.
Yes, you can track NEUBASE THERAPEUTICS INC financials in yearly and quarterly reports right on TradingView.
NBSE net income for the last quarter is ‪−31.74 M‬ MXN, while the quarter before that showed ‪−59.08 M‬ MXN of net income which accounts for 46.27% change. Track more NEUBASE THERAPEUTICS INC financial stats to get the full picture.
Today NEUBASE THERAPEUTICS INC has the market capitalization of ‪28.37 M‬, it has increased by 5.09% over the last week.
No, NBSE doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
Like other stocks, NBSE shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade NEUBASE THERAPEUTICS INC stock right from TradingView charts — choose your broker and connect to your account.
NBSE reached its all-time high on Jul 13, 2021 with the price of 1760.20 MXN, and its all-time low was 21.00 MXN and was reached on May 10, 2022.
See other stocks reaching their highest and lowest prices.